Study guide
6.5 Vaccine Prescribing & Administration: Age Floors, Protocols, Training & ALERT IIS
Oregon Multistate Pharmacy Jurisprudence Examination MPJE
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Exam Overview & Oregon Legal Framework
1.1 Oregon MPJE Format, Fees, Blueprint & 2027 Changes 1.2 Federal–Oregon Legal Hierarchy, Agencies & the Board of Pharmacy
2 Chapter 2: Pharmacist & Pharmacist-in-Charge Responsibilities
2.1 Pharmacist Responsibilities, Supervision & Prohibited Practices 2.2 Pharmacist-in-Charge: Qualifications, Duties, Inventories & Self-Inspection
3 Chapter 3: Pharmacy Technicians, Interns & Preceptors
3.1 Pharmacy Technicians (COPT & PT): Licensure, Permitted Tasks & Limits 3.2 Pharmacy Interns & Preceptors: Licensure, Scope & Supervision
4 Chapter 4: Licensure, Renewal, Discipline & Impaired Practitioners
4.1 Pharmacist Licensure by Examination, Score Transfer & Reciprocity 4.2 License Renewal, Continuing Pharmacy Education & Lapse Rules 4.3 Grounds for Discipline, Sanctions & Mandatory Reporting Deadlines 4.4 Impaired Practitioners & the Health Professionals' Services Program (HPSP)
5 Chapter 5: Prescriber Authority & Prescription Requirements
5.1 Prescriber Authority, DEA Registration & Out-of-State Prescriptions 5.2 Non-Controlled Prescriptions: Required Elements, Signatures, Expiration & Refills 5.3 Controlled Substance Prescriptions: Schedules II–V, EPCS, Emergency Orders & Oregon's CV Limit 5.4 Drug-Use Limitations & Special Prescriptions: REMS, Death with Dignity, EPT & Standing Orders 5.5 Legitimate Medical Purpose, Corresponding Responsibility & Red Flags
6 Chapter 6: Pharmacist Clinical Services & Prescriptive Authority
6.1 CDTM, Clinical Pharmacy Agreements, MTM & Laboratory Testing 6.2 Pharmacist Prescribing: Statewide Protocols, the Formulary & General Requirements 6.3 Pharmacist Prescribing of Hormonal Contraception (ORS 689.689) 6.4 Tobacco Cessation Protocol: Training, Screening, NRT & Non-NRT Prescribing 6.5 Vaccine Prescribing & Administration: Age Floors, Protocols, Training & ALERT IIS 6.6 Opioid Overdose Reversal & MOUD: Naloxone Prescribing, Standing Orders, Immunity & Buprenorphine
7 Chapter 7: Counseling, Language Access & Confidentiality
7.1 Patient Counseling: Triggers, Who May Offer or Accept a Refusal & Documentation 7.2 Language Access & Accessibility: Dual-Language Labels, Registry Interpreters & Prescription Readers 7.3 Patient Confidentiality: Oregon Rules, HIPAA, Part 2 & PDMP Privacy
8 Chapter 8: The Dispensing Process
8.1 Prospective Drug Utilization Review: Oregon's Eight Categories, Documentation & Who May Perform It 8.2 Oregon PDMP: Reporting Within 72 Hours, Covered Drugs, Access & Confidentiality 8.3 Prescription Transfers: Oregon's Next-Business-Day Duty & Federal Controlled Substance Limits 8.4 Dispensing Exceptions: 72-Hour Emergency Refills, Continuation of Therapy, Insulin & Declared Emergencies 8.5 Partial Fills: Schedule II (72-Hour, 30-Day CARA & 60-Day LTCF/Terminal) and Schedules III–V 8.6 Prescription Labeling: Oregon Elements, Physical Description, Expiration Dating & Med Paks 8.7 Packaging: PPPA Child-Resistant Containers, Waivers, Exemptions & Oregon's New-Container Rule 8.8 Conditions Prohibiting Dispensing, Quarantine, Returned Drugs & Charitable Reuse
9 Chapter 9: Nonprescription & Restricted Products
9.1 Nonprescription Drugs: Outlet Registration, Drug Facts Labeling & OTC Packaging 9.2 Dispensing-Restricted Nonprescription Products: Pseudoephedrine, Exempt Schedule V & Others
10 Chapter 10: Product Selection: Generic & Biologic Substitution
10.1 Product Selection: Generic Substitution (ORS 689.515) & Biologic Interchange (ORS 689.522)
11 Chapter 11: Acquisition, Records, Inventories & Loss Reporting
11.1 Ordering & Acquiring Controlled Substances: DEA Registration, Form 222, CSOS & the 5% Rule 11.2 Distribution Records, DSCSA, Recalls & Oregon Record Retention 11.3 Controlled Substance Inventories: Oregon's 367-Day, 93-Day, 31-Day & 15-Day Rules 11.4 Theft & Loss Reporting, Disposal, Reverse Distribution & Take-Back Receptacles
12 Chapter 12: Pharmacy Operations, Storage, Security & Special Practice Settings
12.1 Pharmacy Operations: Pharmacist Presence, Policies, Equipment, Signage, Hours & Closures 12.2 Drug Storage & Cold Chain: Temperatures, Monitoring Plans, Excursions & Vaccine Units 12.3 Security & Non-Pharmacist Access: Keys, Double Set-Ups, Institutional Night Access & DEA Controls 12.4 Hazardous Drugs: NIOSH 2024 List, USP 800 Controls, Assessment of Risk & Disposal 12.5 Compounding: OAR 855-183 (June 2026), USP 795/797/800, 503A vs. 503B & Beyond-Use Dates 12.6 Delivery of Drugs: Depots, Mail Delivery, Prescription Lockers, Kiosks & Mobile Pharmacies 12.7 Central Fill, Remote Processing, Telework & Remote Dispensing Site Pharmacies
13 Chapter 13: Drug Outlet Registration, Inspection & Institutional Practice
13.1 Drug Outlet Classes, Registration, Changes of Ownership/Location/Name & Non-Resident Pharmacies 13.2 Inspections, Self-Inspection Forms & Discipline of Drug Outlets 13.3 Institutional & Long-Term Care Practice: Drug Rooms, Night Access, E-Kits, ADCs & ED Prepacks
6.5 Vaccine Prescribing & Administration: Age Floors, Protocols, Training & ALERT IIS
Key Takeaways Explain This Topic AI
Oregon pharmacists and supervised technicians may vaccinate people aged 7 and older, give influenza vaccine from 6 months, and vaccinate from age 3 only under a qualifying emergency authorization (ORS 689.645).
The Oregon Board repealed its vaccine protocols for ages 3–6 and 6 months–2 years in January 2026, leaving protocols for adults and for ages 7–17 plus COVID-19, influenza and RSV.
Oregon immunizing pharmacists need practical injection training, emergency-reaction training and age-appropriate healthcare-provider CPR with a hands-on component, valid no more than three years.
In Oregon, the pharmacist or a trained intern reviews ALERT IIS and selects the vaccine, and a trained technician may only perform the injection for patients 7 and older.
Oregon vaccine records include the lot, expiration date, route, site and administering licensee, and doses are reported to ALERT IIS within OHA's 14-day window.
Last updated: October 2026
Why this matters
Vaccine questions are common and change often. Oregon's statute sets age floors . The Board's rules set training and record duties. Since 2025, the Board's protocols have tied pharmacist vaccination to specific dated ACIP recommendations and to West Coast Health Alliance (WCHA) guidance for respiratory vaccines. Many older study aids use repealed age thresholds.
Who may be vaccinated (ORS 689.645(1)(a))
A pharmacist , or a pharmacy technician under a pharmacist's supervision , may administer vaccines:
- Patient Authority
- 7 years of age or older Any vaccine covered by a Board protocol
- 6 months or older Influenza vaccine only
3 years or older Only if authorized by the Governor or the Director of the Oregon Department of Emergency Management under ORS 433.441, or by the Public Health Director under ORS 433.443 or 433.444. During such a declared emergency, OAR 855-007-0080 also allows pharmacists to vaccinate persons 3 and older
The Board repealed its standard vaccination protocols for ages 3–6 and 6 months–2 years in January 2026. Outside the influenza exception and emergency authorizations, a non-influenza vaccine for a child under 7 needs another lawful authority, such as a patient-specific order from a prescriber, which a pharmacist may administer under ORS 689.655.
The current Board protocols (OAR 855-115-0345)
Standard Vaccination Protocol for Adults 18 and Older and for Persons 7 through 17 (v. 09/2026). The pharmacist may prescribe, dispense and administer listed vaccines according to ACIP recommendations adopted by reference as of specific dates , the CDC Pink Book and Yellow Book, and Board rules. Examples include Tdap, HPV, hepatitis A and B, MMR, meningococcal, pneumococcal, polio, varicella, and travel vaccines such as typhoid, Japanese encephalitis, rabies and yellow fever.
Separate protocols for COVID-19, influenza and RSV , which reflect WCHA recommendations (influenza v. 09/2026). For example, the influenza protocol covers persons 6 months and older IM, live attenuated (intranasal) vaccine for ages 2 and older , and two doses at least 28 days apart for children under 9 receiving influenza vaccine for the first time.
Protocol for Managing Adverse Reactions , which every immunizing site must have along with the required equipment and supplies.
Training and readiness (OAR 855-115-0305)
Before administering, the pharmacist must:
Complete practical training in the injection site and technique used.
Complete training in hands-on injection technique , clinical evaluation of indications and contraindications , and recognition and treatment of emergency reactions .
Hold current CPR certification for health care providers, from the American Heart Association, the American Red Cross or an equivalent. It must include a hands-on component , be specific to the age of the population being vaccinated, and be valid for no more than three years .
Ensure the vaccine was stored under OAR 855-041-1036.
The Board may issue certificates of special competency in vaccine prescribing or administration (ORS 689.645(3)). Training records are kept six years or uploaded to eGov (OAR 855-104-0055).
Who does what in the encounter
The pharmacist , or a trained intern past the first academic year, reviews ALERT IIS , makes the recommendation and selects the vaccine (OAR 855-115-0305(3)).
A trained technician may perform only the physical act of administration , for patients 7 and older (OAR 855-125-0305).
The Vaccine Information Statement (VIS) must be given before each dose (42 U.S.C. 300aa-26).
Records and reporting
The administering licensee records:
The patient identifier and the administering licensee identifier.
The vaccine, dose, lot number and expiration date .
The route and site.
The date and time.
The pharmacist must ensure reporting to ALERT IIS (OAR 855-115-0125(9)(a)). OHA's IIS rule sets a 14-calendar-day reporting window for participating providers (OAR 333-049-0050). Clinically significant adverse events and errors are reported to VAERS . Under ORS 689.645(4), the Board's rules address reporting to the patient's primary care provider and to OHA.
Warning
Many older materials state that Oregon pharmacists may give all ACIP vaccines from age 3 and must report to ALERT IIS within 15 days . Under current law, the routine floor is age 7 (age 6 months for influenza), age 3 applies only under an emergency authorization, and the current IIS rule sets a 14-day window.
Managing anaphylaxis
The Board's adverse-reaction protocol follows standard emergency care:
Give intramuscular epinephrine (1 mg/mL) into the anterolateral thigh at the weight-based dose, up to 0.5 mg in adults (often 0.3 mg by auto-injector).
Call 911.
Position the patient appropriately.
Repeat epinephrine every 5–15 minutes if needed.
Give antihistamines only as adjuncts.
Patients are typically observed for 15 minutes after vaccination, or 30 minutes with a history of immediate reactions.
Exam scenario
A parent brings a 5-year-old for a seasonal flu shot and a varicella booster, with no prescription and no emergency declaration in effect. The pharmacist may give the influenza vaccine under the influenza protocol (6 months and older). They may not give varicella under a protocol, because the child is under 7, and the 3-year emergency authority isn't active. A licensed technician may not administer either dose to this child, because technician administration is limited to ages 7 and up.